Blood test may help identify which colorectal cancer patients most likely to benefit from chemotherapy after surgery

Дата публикации: 06-07-2026 19:20:01

A blood test may help identify which patients with colorectal cancer that has spread to the liver are most likely to benefit from chemotherapy after surgery, according to research presented today at the ESMO Gastrointestinal Cancers Congress 2026.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Blood Test May Help Identify Which Colorectal Cancer Patients with Liver Metastases Are Most Likely to Benefit from Chemotherapy After Surgery	0	7	03-07-2026
2	Hidden metastases reveal clues to colorectal cancer recurrence	3	7	09-07-2026
3	Fatty liver drives a more dangerous form of colorectal cancer spread, study reveals	5	8	01-07-2026
4	Novel biomarker research offers new hope in the fight against colorectal cancer	7	8	06-07-2026
5	New targeted therapy shows promising early results in advanced pancreatic cancer	2	7	05-07-2026
6	No Difference in DFS Between Post-adjuvant Chemotherapy and Placebo In High-Risk Patients Identified Through ctDNA-based MRD Assessment After CRC Resection	0	5	22-06-2026
7	New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer	5	7	02-07-2026
8	EMA Recommends Extension of Therapeutic Indications for Encorafenib	0	5	03-07-2026
9	Researchers expand plasmonic liquid biopsy platform to early-stage colorectal cancer	5	7	09-07-2026
10	Ultrasensitive blood test predicts head and neck cancer relapse months earlier	5	7	10-06-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 5. Источник: medicalxpress.com.